Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ - 26/08/11
Abstract |
Background |
Recent studies report the incidence of axillary metastases in patients with ductal carcinoma in-situ (DCIS) approaches 13%. The purpose of this study was to define the incidence of axillary micrometastases in patients with pure DCIS before and after the introduction of sentinel lymph node biopsy.
Methods |
Patients with a final diagnosis of DCIS form the basis of this study. Data were entered prospectively into an Institutional Review Board approved Oracle database from January 1997 through July 2002.
Results |
One hundred and thirty-four patients had lymph nodes evaluated. Ninety-eight percent of patients had no evidence of metastatic disease and 2% were found to have micrometastases. This was consistent in those who had level I or II lymph node sampling or both and those who had lymphatic mapping and a sentinel lymph node biopsy procedure.
Conclusions |
These data do not support axillary lymph node removal of any type in patients with pure DCIS.
Le texte complet de cet article est disponible en PDF.Keywords : Ductal carcinoma in-situ, Intraductal carcinoma, Sentinel lymph node biopsy
Plan
Vol 186 - N° 4
P. 368-370 - octobre 2003 Retour au numéro
Article précédent
- Low-risk palpable breast masses removed using a vacuum-assisted hand-held device
- Richard E Fine, Pat W Whitworth, Julian A Kim, Jay K Harness, Beth A Boyd, William E Burak
- Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery
- Anees Chagpar, Tina Yen, Aysegul Sahin, Kelly K Hunt, Gary J Whitman, Frederick C Ames, Merrick I Ross, Funda Meric-Bernstam, Gildy V Babiera, S.Eva Singletary, Henry M Kuerer
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?